Matches in SemOpenAlex for { <https://semopenalex.org/work/W4294983013> ?p ?o ?g. }
- W4294983013 endingPage "1062" @default.
- W4294983013 startingPage "1033" @default.
- W4294983013 abstract "The classic Philadelphia chromosome-negative myeloproliferative neoplasms (MPN) consist of myelofibrosis, polycythemia vera, and essential thrombocythemia and are a heterogeneous group of clonal blood disorders characterized by an overproduction of blood cells. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for MPN were developed as a result of meetings convened by a multidisciplinary panel with expertise in MPN, with the goal of providing recommendations for the management of MPN in adults. The Guidelines include recommendations for the diagnostic workup, risk stratification, treatment, and supportive care strategies for the management of myelofibrosis, polycythemia vera, and essential thrombocythemia. Assessment of symptoms at baseline and monitoring of symptom status during the course of treatment is recommended for all patients. This article focuses on the recommendations as outlined in the NCCN Guidelines for the diagnosis of MPN and the risk stratification, management, and supportive care relevant to MF." @default.
- W4294983013 created "2022-09-08" @default.
- W4294983013 creator A5002235720 @default.
- W4294983013 creator A5002632381 @default.
- W4294983013 creator A5011529063 @default.
- W4294983013 creator A5013173470 @default.
- W4294983013 creator A5015755664 @default.
- W4294983013 creator A5015788207 @default.
- W4294983013 creator A5020437681 @default.
- W4294983013 creator A5020976414 @default.
- W4294983013 creator A5022887326 @default.
- W4294983013 creator A5023728016 @default.
- W4294983013 creator A5024612499 @default.
- W4294983013 creator A5030193536 @default.
- W4294983013 creator A5031822497 @default.
- W4294983013 creator A5034639636 @default.
- W4294983013 creator A5038004259 @default.
- W4294983013 creator A5040225749 @default.
- W4294983013 creator A5040436353 @default.
- W4294983013 creator A5046091655 @default.
- W4294983013 creator A5047764826 @default.
- W4294983013 creator A5047939331 @default.
- W4294983013 creator A5051485142 @default.
- W4294983013 creator A5060296758 @default.
- W4294983013 creator A5061036070 @default.
- W4294983013 creator A5063698376 @default.
- W4294983013 creator A5065595440 @default.
- W4294983013 creator A5065621786 @default.
- W4294983013 creator A5066543172 @default.
- W4294983013 creator A5070193149 @default.
- W4294983013 creator A5081918771 @default.
- W4294983013 creator A5090985347 @default.
- W4294983013 creator A5091612581 @default.
- W4294983013 date "2022-09-01" @default.
- W4294983013 modified "2023-10-12" @default.
- W4294983013 title "Myeloproliferative Neoplasms, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology" @default.
- W4294983013 cites W1503482160 @default.
- W4294983013 cites W1534089060 @default.
- W4294983013 cites W1545484310 @default.
- W4294983013 cites W1571132152 @default.
- W4294983013 cites W1583257954 @default.
- W4294983013 cites W1607057462 @default.
- W4294983013 cites W1766283728 @default.
- W4294983013 cites W1821109160 @default.
- W4294983013 cites W1913728377 @default.
- W4294983013 cites W1918141746 @default.
- W4294983013 cites W1924834505 @default.
- W4294983013 cites W1943058608 @default.
- W4294983013 cites W1966357810 @default.
- W4294983013 cites W1971385655 @default.
- W4294983013 cites W1972610696 @default.
- W4294983013 cites W1972850303 @default.
- W4294983013 cites W1976479449 @default.
- W4294983013 cites W1977174953 @default.
- W4294983013 cites W1978522712 @default.
- W4294983013 cites W1980568348 @default.
- W4294983013 cites W1984143879 @default.
- W4294983013 cites W1985619207 @default.
- W4294983013 cites W1987463051 @default.
- W4294983013 cites W1989635000 @default.
- W4294983013 cites W1991495650 @default.
- W4294983013 cites W1993214853 @default.
- W4294983013 cites W1995149934 @default.
- W4294983013 cites W1996742853 @default.
- W4294983013 cites W1999000517 @default.
- W4294983013 cites W1999664208 @default.
- W4294983013 cites W1999701140 @default.
- W4294983013 cites W2005491291 @default.
- W4294983013 cites W2005987994 @default.
- W4294983013 cites W2006467209 @default.
- W4294983013 cites W2008136854 @default.
- W4294983013 cites W2008799537 @default.
- W4294983013 cites W2010298229 @default.
- W4294983013 cites W2010507912 @default.
- W4294983013 cites W2011253478 @default.
- W4294983013 cites W2014091629 @default.
- W4294983013 cites W2014588302 @default.
- W4294983013 cites W2017073234 @default.
- W4294983013 cites W2017821630 @default.
- W4294983013 cites W2018254868 @default.
- W4294983013 cites W2020294706 @default.
- W4294983013 cites W2021443159 @default.
- W4294983013 cites W2022290794 @default.
- W4294983013 cites W2023809476 @default.
- W4294983013 cites W2024401882 @default.
- W4294983013 cites W2025109100 @default.
- W4294983013 cites W2026588020 @default.
- W4294983013 cites W2027616756 @default.
- W4294983013 cites W2028334401 @default.
- W4294983013 cites W2029529782 @default.
- W4294983013 cites W2029818817 @default.
- W4294983013 cites W2030716854 @default.
- W4294983013 cites W2030868349 @default.
- W4294983013 cites W2031978224 @default.
- W4294983013 cites W2033210181 @default.
- W4294983013 cites W2033914091 @default.
- W4294983013 cites W2036058848 @default.
- W4294983013 cites W2036744066 @default.